<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-30T12:22:25Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-8583.000016">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-8583.000016</identifier>
									<datestamp>2017-02-03</datestamp>
									<setSpec>PTZ.GJODMS:VOL4</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Nutrigenomics Coupling with other OMICS Platform Enhance Personalized Health Care in Metabolic Disorders
										</dc:title><dc:creator>Sylvester Ndimele</dc:creator><dc:creator> Miranda L. Carpenter</dc:creator><dc:creator> Jae-Hyeon Cho</dc:creator><dc:creator>Hong Duck Kim</dc:creator><dc:description>&lt;p&gt;Diabetes is a multifactorial of diseases characterized by high blood glucose levels which occur as a result in the body’s inability to produce and/or use insulin. Both type 1 and 2 diabetes are thought to be complex disease which developed by the influence of many susceptibility and protective genes, in relation with negative and positive environmental factors. Though type 1 diabetes is distinguished by common beta-cell loss which is mediated by an autoimmune process to extent that all patients with overt type 1 diabetes will essentially need insulin. Multiple genetic factors have been connected to type 1 diabetes which can define individualized plan for type 1 prevention. This review has focused on type 2 diabetes (T2D) which has become more and more a challenging health burden as a result of its degree of morbidity, mortality and heightened prevalence worldwide.&lt;/p&gt;</dc:description>
										<dc:publisher>Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications</dc:publisher>
										<dc:date>2017-02-03</dc:date>
										<dc:type>Short Communication</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-8583.000016</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Sylvester Ndimele et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
